The National Committee for Quality Assurance is a private, 501(c)(3) not-for-profit organization dedicated to improving health care quality. Since its founding in 1990, NCQA has been a central figure in driving improvement throughout the health care system, helping to elevate the issue of health care quality to the top of the national agenda.
The NCQA seal is a widely recognized symbol of quality. Organizations incorporating the seal into advertising and marketing materials must first pass a rigorous, comprehensive review and must annually report on their performance. For consumers and employers, the seal is a reliable indicator that an organization is well-managed and delivers high quality care and service.
NCQA has helped to build consensus around important health care quality issues by working with large employers, policymakers, doctors, patients and health plans to decide what’s important, how to measure it, and how to promote improvement. That consensus is invaluable — transforming our health care system requires the collected will and resources of all these constituencies and more.
Thursday, June 17, 2010
TYELNOL RECALL
June 15, 2010
Dear Healthcare Professional:
I am writing to inform you that McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc. is voluntarily recalling five product lots as an addition to the list of products included in the company's January 15th, 2010 product recall. The additional lots involved are four product lots of BENADRYL® ALLERGY ULTRATAB™ TABLETS, 100 count, sold in the U.S.; and one product lot of EXTRA STRENGTH TYLENOL® Rapid Release Gels, 50 count, sold in the U.S., Trinidad and Tobago, Bermuda, and Puerto Rico (FULL RECALLED PRODUCT LIST BELOW). This recall is being conducted with the knowledge of the U.S Food and Drug Administration. McNeil is providing the following information to consumers on the www.mcneilproductrecall.com Web site.
MCNEIL CONSUMER HEALTHCARE RECALLS FOUR PRODUCT LOTS OF BENADRYL® ALLERGY ULTRATAB™ TABLETS, 100 COUNT, AND ONE PRODUCT LOT OF EXTRA STRENGTH TYLENOL® RAPID RELEASE GELS, 50 COUNT
Fort Washington, PA (June 15, 2010) - McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc., is recalling five product lots as an addition to the list of products included in the company's January 15th, 2010 product recall. The additional lots involved are four product lots of BENADRYL® ALLERGY ULTRATAB™ TABLETS, 100 count, sold in the U.S.; and one product lot of EXTRA STRENGTH TYLENOL® Rapid Release Gels, 50 count, sold in the U.S., Trinidad and Tobago, Bermuda, and Puerto Rico (FULL RECALLED PRODUCT LIST BELOW). This recall is a follow-up to the product recall that McNeil Consumer Healthcare announced on January 15th, 2010 and is being taken because the products were inadvertently omitted from the initial recall action. McNeil Consumer Healthcare identified the omission and informed the U.S. Food and Drug Administration (FDA) of its decision to add these product lots to the recall list. All of these products were produced before the January 15th, 2010 recall. Since January, McNeil Consumer Healthcare has continued to analyze and evaluate 2,4,6-tribromoanisole (TBA) and has shared that information with the FDA. This further analysis confirms that the risk of serious adverse medical events is remote. This recall is being conducted with the knowledge of the FDA.
BENADRYL® ALLERGY ULTRATAB™ TABLETS is sold over-the-counter and is indicated for the relief of allergy associated symptoms such as sneezing, runny nose, itchy throat, and itchy and watery eyes. EXTRA STRENGTH TYLENOL® Rapid Release Gels is sold over-the-counter and is indicated for the temporary reduction of fever and for the temporary relief of minor aches and pains due to headache, muscular aches, backache, minor arthritis pain, the common cold, toothache, pre-menstrual and menstrual cramps, and flu.
The January 15th, 2010 recall was initiated as a result of consumer complaints of a musty or moldy odor that has since been linked to the presence of trace amounts of a chemical called 2,4,6-tribromoanisole (TBA). After a thorough investigation, it was determined that the source of TBA was the result of a breakdown of a chemical that is applied to wood used to build wooden pallets that transport and store product packaging materials.
Consumers who purchased product from the lots included in this recall should stop using the product and contact McNeil Consumer Healthcare for instructions on a refund or replacement. For these instructions or information regarding how to return or dispose of the product, consumers should log on to the internet at www.mcneilproductrecall.com or call 1-888-222-6036 (Monday-Friday 8 a.m. to 8 p.m. Eastern Time, and Saturday-Sunday 9 a.m. to 5 p.m. Eastern Time). Requests for reimbursement can be made at www.mcneilproductrecall.com. Consumers who have medical concerns or questions should contact their healthcare provider.
Any adverse reactions may also be reported to the FDA's MedWatch Program by fax at 1-800-FDA-0178, by mail at MedWatch, HF-2, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787, or on the MedWatch website at http://www.fda.gov/safety/medwatch/default.htm.
The product lot numbers for the recalled products can be found on the side of the bottle label.
If you have any questions yourself, please call our Medical Affairs Department at 1-866-948-6883 (available Monday-Friday 8 a.m. to 8 p.m. Eastern Time) or visit our dedicated Web site for Healthcare Professionals at TylenolProfessional.com.
Sincerely,
Edwin K. Kuffner, MD
Vice President, Medical Affairs
McNeil Consumer Healthcare
FULL RECALLED PRODUCT LIST:
Product Code Product Name Lot Number UPC Code
TYLENOL® EXTRA STRENGTH RAPID RELEASE GELCAPS
4885000 TYLENOL® EXTRA STRENGTH RAPID RELEASE GELCAPS 50 ct
BENADRYL® ALLERGY ULTRATAB™ TABLETS
1703302 BENADRYL® ALLERGY ULTRATAB™ Tablets 100 ct
You are receiving this email because you have opted-in to receive communications from McNeil Consumer Healthcare. Please do not respond to this email, since it is not enabled to process responses. If you have any questions, email us or call us at 1-866-948-6883, Monday through Friday, 9 am to 4:30 pm EST. Also, please add info@TylenolProfessional.com to your address book or email safelist so that future emails from us can reach you.
If you do not wish to receive future communications from TylenolProfessional.com, you can unsubscribe.
7050 Camp Hill Road
Fort Washington, PA 19034, USA
©McNEIL-PPC, Inc. 2010
Dear Healthcare Professional:
I am writing to inform you that McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc. is voluntarily recalling five product lots as an addition to the list of products included in the company's January 15th, 2010 product recall. The additional lots involved are four product lots of BENADRYL® ALLERGY ULTRATAB™ TABLETS, 100 count, sold in the U.S.; and one product lot of EXTRA STRENGTH TYLENOL® Rapid Release Gels, 50 count, sold in the U.S., Trinidad and Tobago, Bermuda, and Puerto Rico (FULL RECALLED PRODUCT LIST BELOW). This recall is being conducted with the knowledge of the U.S Food and Drug Administration. McNeil is providing the following information to consumers on the www.mcneilproductrecall.com Web site.
MCNEIL CONSUMER HEALTHCARE RECALLS FOUR PRODUCT LOTS OF BENADRYL® ALLERGY ULTRATAB™ TABLETS, 100 COUNT, AND ONE PRODUCT LOT OF EXTRA STRENGTH TYLENOL® RAPID RELEASE GELS, 50 COUNT
Fort Washington, PA (June 15, 2010) - McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc., is recalling five product lots as an addition to the list of products included in the company's January 15th, 2010 product recall. The additional lots involved are four product lots of BENADRYL® ALLERGY ULTRATAB™ TABLETS, 100 count, sold in the U.S.; and one product lot of EXTRA STRENGTH TYLENOL® Rapid Release Gels, 50 count, sold in the U.S., Trinidad and Tobago, Bermuda, and Puerto Rico (FULL RECALLED PRODUCT LIST BELOW). This recall is a follow-up to the product recall that McNeil Consumer Healthcare announced on January 15th, 2010 and is being taken because the products were inadvertently omitted from the initial recall action. McNeil Consumer Healthcare identified the omission and informed the U.S. Food and Drug Administration (FDA) of its decision to add these product lots to the recall list. All of these products were produced before the January 15th, 2010 recall. Since January, McNeil Consumer Healthcare has continued to analyze and evaluate 2,4,6-tribromoanisole (TBA) and has shared that information with the FDA. This further analysis confirms that the risk of serious adverse medical events is remote. This recall is being conducted with the knowledge of the FDA.
BENADRYL® ALLERGY ULTRATAB™ TABLETS is sold over-the-counter and is indicated for the relief of allergy associated symptoms such as sneezing, runny nose, itchy throat, and itchy and watery eyes. EXTRA STRENGTH TYLENOL® Rapid Release Gels is sold over-the-counter and is indicated for the temporary reduction of fever and for the temporary relief of minor aches and pains due to headache, muscular aches, backache, minor arthritis pain, the common cold, toothache, pre-menstrual and menstrual cramps, and flu.
The January 15th, 2010 recall was initiated as a result of consumer complaints of a musty or moldy odor that has since been linked to the presence of trace amounts of a chemical called 2,4,6-tribromoanisole (TBA). After a thorough investigation, it was determined that the source of TBA was the result of a breakdown of a chemical that is applied to wood used to build wooden pallets that transport and store product packaging materials.
Consumers who purchased product from the lots included in this recall should stop using the product and contact McNeil Consumer Healthcare for instructions on a refund or replacement. For these instructions or information regarding how to return or dispose of the product, consumers should log on to the internet at www.mcneilproductrecall.com or call 1-888-222-6036 (Monday-Friday 8 a.m. to 8 p.m. Eastern Time, and Saturday-Sunday 9 a.m. to 5 p.m. Eastern Time). Requests for reimbursement can be made at www.mcneilproductrecall.com. Consumers who have medical concerns or questions should contact their healthcare provider.
Any adverse reactions may also be reported to the FDA's MedWatch Program by fax at 1-800-FDA-0178, by mail at MedWatch, HF-2, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787, or on the MedWatch website at http://www.fda.gov/safety/medwatch/default.htm.
The product lot numbers for the recalled products can be found on the side of the bottle label.
If you have any questions yourself, please call our Medical Affairs Department at 1-866-948-6883 (available Monday-Friday 8 a.m. to 8 p.m. Eastern Time) or visit our dedicated Web site for Healthcare Professionals at TylenolProfessional.com.
Sincerely,
Edwin K. Kuffner, MD
Vice President, Medical Affairs
McNeil Consumer Healthcare
FULL RECALLED PRODUCT LIST:
Product Code Product Name Lot Number UPC Code
TYLENOL® EXTRA STRENGTH RAPID RELEASE GELCAPS
4885000 TYLENOL® EXTRA STRENGTH RAPID RELEASE GELCAPS 50 ct
BENADRYL® ALLERGY ULTRATAB™ TABLETS
1703302 BENADRYL® ALLERGY ULTRATAB™ Tablets 100 ct
You are receiving this email because you have opted-in to receive communications from McNeil Consumer Healthcare. Please do not respond to this email, since it is not enabled to process responses. If you have any questions, email us or call us at 1-866-948-6883, Monday through Friday, 9 am to 4:30 pm EST. Also, please add info@TylenolProfessional.com to your address book or email safelist so that future emails from us can reach you.
If you do not wish to receive future communications from TylenolProfessional.com, you can unsubscribe.
7050 Camp Hill Road
Fort Washington, PA 19034, USA
©McNEIL-PPC, Inc. 2010
Thursday, May 6, 2010
McNeil Consumer Healthcare Announces Voluntary Recall of Certain OTC Infants’ and Children’s Products
McNeil Consumer Healthcare Announces Voluntary Recall of Certain OTC Infants’ and Children’s Products
McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc., in consultation with the U.S. Food and Drug Administration (FDA), is voluntarily recalling all lots that have not yet expired of certain over-the-counter (OTC) Children's and Infants' liquid products manufactured in the United States and distributed in the United States, Canada, Dominican Republic, Dubai (UAE), Fiji, Guam, Guatemala, Jamaica, Puerto Rico, Panama, Trinidad & Tobago, and Kuwait.
McNeil Consumer Healthcare is initiating this voluntary recall because some of these products may not meet required quality standards. This recall is not being undertaken on the basis of adverse medical events. However, as a precautionary measure, parents and caregivers should not administer these products to their children. Some of the products included in the recall may contain a higher concentration of active ingredient than is specified; others may contain inactive ingredients that may not meet internal testing requirements; and others may contain tiny particles. While the potential for serious medical events is remote, the company advises consumers who have purchased these recalled products to discontinue use.
The company is conducting a comprehensive quality assessment across its manufacturing operations and has identified corrective actions that will be implemented before new manufacturing is initiated at the plant where the recalled products were made.
Consumers can contact the company at 1-888-222-6036 and also at www.mcneilproductrecall.com. Parents and caregivers who are not sure about alternative pediatric health treatment options should talk to their doctor or pharmacist and are reminded to never give drug products to infants and children that are not intended for those age groups as this could result in serious harm.
For additional information, including affected NDC numbers, consumers should visit our website www.mcneilproductrecall.com or call 1-888-222-6036 (Monday-Friday 8 a.m. to 10 p.m. Eastern Time, and Saturday-Sunday 9 a.m. to 5 p.m. Eastern Time). Any adverse reactions may also be reported to the FDA’s MedWatch Program by fax at 1-800-FDA-0178, by mail at MedWatch, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787, or on the MedWatch website at www.fda.gov/medwatch.
McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc., in consultation with the U.S. Food and Drug Administration (FDA), is voluntarily recalling all lots that have not yet expired of certain over-the-counter (OTC) Children's and Infants' liquid products manufactured in the United States and distributed in the United States, Canada, Dominican Republic, Dubai (UAE), Fiji, Guam, Guatemala, Jamaica, Puerto Rico, Panama, Trinidad & Tobago, and Kuwait.
McNeil Consumer Healthcare is initiating this voluntary recall because some of these products may not meet required quality standards. This recall is not being undertaken on the basis of adverse medical events. However, as a precautionary measure, parents and caregivers should not administer these products to their children. Some of the products included in the recall may contain a higher concentration of active ingredient than is specified; others may contain inactive ingredients that may not meet internal testing requirements; and others may contain tiny particles. While the potential for serious medical events is remote, the company advises consumers who have purchased these recalled products to discontinue use.
The company is conducting a comprehensive quality assessment across its manufacturing operations and has identified corrective actions that will be implemented before new manufacturing is initiated at the plant where the recalled products were made.
Consumers can contact the company at 1-888-222-6036 and also at www.mcneilproductrecall.com. Parents and caregivers who are not sure about alternative pediatric health treatment options should talk to their doctor or pharmacist and are reminded to never give drug products to infants and children that are not intended for those age groups as this could result in serious harm.
For additional information, including affected NDC numbers, consumers should visit our website www.mcneilproductrecall.com or call 1-888-222-6036 (Monday-Friday 8 a.m. to 10 p.m. Eastern Time, and Saturday-Sunday 9 a.m. to 5 p.m. Eastern Time). Any adverse reactions may also be reported to the FDA’s MedWatch Program by fax at 1-800-FDA-0178, by mail at MedWatch, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787, or on the MedWatch website at www.fda.gov/medwatch.
Wednesday, April 21, 2010
Diabetic Education Class
We had a great turnout for our class on diabetes that was held on April 15, 2010. The crowd was very interactive with questions during this session.
We learned about good blood sugar control. What is diabetes, meal planning and physical activity and special situations. Information to take home was give to each participant about knowing and understaning your treatment for your diabetes.
We look forward to our next Diabetic class which is scheduled for May 20, 2010 at 2pm in the Mackey Family Practice Educational Center. To register for this class please contact our office at 803-285-7414. We look forward to seeing you there.
We learned about good blood sugar control. What is diabetes, meal planning and physical activity and special situations. Information to take home was give to each participant about knowing and understaning your treatment for your diabetes.
We look forward to our next Diabetic class which is scheduled for May 20, 2010 at 2pm in the Mackey Family Practice Educational Center. To register for this class please contact our office at 803-285-7414. We look forward to seeing you there.
Tuesday, April 13, 2010
Weight Management
We had a great time at our WEIGHT MANAGEMENT class on April 8, 2010. There were 15 in attendance.
We learned that in order to lose weight we must eat a diet low in fat and carbohydrates, and control our portion sizes. We must also make better choices when it comes to food selections. Some recommendations would be to eat more fresh fruits and vegetables and DON'T SNACK BETWEEN MEALS.
We also learned the benifits of regular exercise. Just 30 minutes a day of moderate exercise can reduce our risk of diseases such as: Diabetes, heart disease, cancer, dementia and strokes. THAT'S RIGHT.....JUST 30 MINUTES A DAY!!
So let's GET UP AND MOVE. YOU are the ONLY one in control of YOUR body. YOU control what goes in your mouth and whether you are going to exercise or not. No one can make these decesions for you.
A special word of thanks is extended to Lori Mosley, NP from the Gregory Health and Wellness Center and Eddie Haughy from Anytime Fitness for a very informative class.
For more information regarding other FREE classes at Mackey Family Practice please visit our website http://www.mackeyfamilypractice.com/ or contact our office at 803-285-7414.
We learned that in order to lose weight we must eat a diet low in fat and carbohydrates, and control our portion sizes. We must also make better choices when it comes to food selections. Some recommendations would be to eat more fresh fruits and vegetables and DON'T SNACK BETWEEN MEALS.
We also learned the benifits of regular exercise. Just 30 minutes a day of moderate exercise can reduce our risk of diseases such as: Diabetes, heart disease, cancer, dementia and strokes. THAT'S RIGHT.....JUST 30 MINUTES A DAY!!
So let's GET UP AND MOVE. YOU are the ONLY one in control of YOUR body. YOU control what goes in your mouth and whether you are going to exercise or not. No one can make these decesions for you.
A special word of thanks is extended to Lori Mosley, NP from the Gregory Health and Wellness Center and Eddie Haughy from Anytime Fitness for a very informative class.
For more information regarding other FREE classes at Mackey Family Practice please visit our website http://www.mackeyfamilypractice.com/ or contact our office at 803-285-7414.
Tuesday, March 30, 2010
VOLUNTARY RECALL ON TYLENOL
.....per an email that was sent to Mackey Family Practice
March 29, 2010
Dear Healthcare Professional:
I am writing to inform you that, in consultation with the U.S. Food and Drug Administration (FDA),
McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc., is initiating two (2) voluntary recalls: One (1) voluntary recall on certain product lots of Children’s TYLENOL® (acetaminophen) and
Children’s ZYRTEC® syrup (cetirizine HCI), and one (1) voluntary recall on certain product lots of Infants’ TYLENOL® (acetaminophen), Infants’ MOTRIN® (ibuprofen) and Children’s ZYRTEC® Sugar-Free, Dye-Free Bubblegum syrup 15mL bottle physician samples (cetirizine HCl 1mg/mL oral solution antihistamine).
RECALL 1
This voluntary recall includes certain product lots of Children’s TYLENOL® (acetaminophen) and Children’s ZYRTEC® syrup (cetirizine HCI). The Company is initiating this recall at the wholesale and retail levels after determining that a small number of product bottles supplied from one of our external suppliers have specific areas where the bottle plastic is thinner than required by our standard specifications.
As of the date of the recall there had been no reports of adverse events caused by the “thin-walled” bottle defect. The possibility of serious adverse events arising from the use of the product packaged in these bottles is remote, however, as a precaution we are initiating a voluntary recall at the warehouse and retail level for the affected lots. We are initiating the recall because the product may not maintain stability over time due to increased light exposure once the bottle is removed from the outer carton. See TylenolProfessional.com or ZyrtecProfessional.com for a Full Product Recall list.
RECALL 2
The second recall is also a voluntary recall on certain product lots of Infants’ TYLENOL® (acetaminophen), Infants’ MOTRIN® (ibuprofen), and Children’s ZYRTEC® Sugar-Free, Dye-Free Bubblegum syrup 15mL bottle physician samples (cetirizine HCI 1mg/mL oral solution antihistamine) distributed in the United States. The Company is initiating the recall at the wholesale level because the potential exists for the product lot number and/or expiration date printed on the bottle to become illegible as a result of consumer handling over the life of the product. To date there have been no reports of adverse events caused by this labeling issue. There are no indications that the absence of these lot numbers and expiration dates will cause adverse events. See TylenolProfessional.com or ZyrtecProfessional.com for a Full Product Recall list.
These are not consumer level recalls. However, patients with general questions should call our
Consumer Care Center at 1-888-543-8255 (available Monday-Friday 8 a.m. to 8 p.m. Eastern Time).
If you have any questions yourself, please call our Medical Affairs Department at 1-866-948-6883 (available Monday-Friday 9 a.m - 4:30 p.m. Eastern Time) or visit our dedicated Web sites for Healthcare Professionals at TylenolProfessional.com or ZyrtecProfessional.com.
Sincerely,
Edwin K. Kuffner, MD
Vice President, Medical Affairs
McNeil Consumer Healthcare
March 29, 2010
Dear Healthcare Professional:
I am writing to inform you that, in consultation with the U.S. Food and Drug Administration (FDA),
McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc., is initiating two (2) voluntary recalls: One (1) voluntary recall on certain product lots of Children’s TYLENOL® (acetaminophen) and
Children’s ZYRTEC® syrup (cetirizine HCI), and one (1) voluntary recall on certain product lots of Infants’ TYLENOL® (acetaminophen), Infants’ MOTRIN® (ibuprofen) and Children’s ZYRTEC® Sugar-Free, Dye-Free Bubblegum syrup 15mL bottle physician samples (cetirizine HCl 1mg/mL oral solution antihistamine).
RECALL 1
This voluntary recall includes certain product lots of Children’s TYLENOL® (acetaminophen) and Children’s ZYRTEC® syrup (cetirizine HCI). The Company is initiating this recall at the wholesale and retail levels after determining that a small number of product bottles supplied from one of our external suppliers have specific areas where the bottle plastic is thinner than required by our standard specifications.
As of the date of the recall there had been no reports of adverse events caused by the “thin-walled” bottle defect. The possibility of serious adverse events arising from the use of the product packaged in these bottles is remote, however, as a precaution we are initiating a voluntary recall at the warehouse and retail level for the affected lots. We are initiating the recall because the product may not maintain stability over time due to increased light exposure once the bottle is removed from the outer carton. See TylenolProfessional.com or ZyrtecProfessional.com for a Full Product Recall list.
RECALL 2
The second recall is also a voluntary recall on certain product lots of Infants’ TYLENOL® (acetaminophen), Infants’ MOTRIN® (ibuprofen), and Children’s ZYRTEC® Sugar-Free, Dye-Free Bubblegum syrup 15mL bottle physician samples (cetirizine HCI 1mg/mL oral solution antihistamine) distributed in the United States. The Company is initiating the recall at the wholesale level because the potential exists for the product lot number and/or expiration date printed on the bottle to become illegible as a result of consumer handling over the life of the product. To date there have been no reports of adverse events caused by this labeling issue. There are no indications that the absence of these lot numbers and expiration dates will cause adverse events. See TylenolProfessional.com or ZyrtecProfessional.com for a Full Product Recall list.
These are not consumer level recalls. However, patients with general questions should call our
Consumer Care Center at 1-888-543-8255 (available Monday-Friday 8 a.m. to 8 p.m. Eastern Time).
If you have any questions yourself, please call our Medical Affairs Department at 1-866-948-6883 (available Monday-Friday 9 a.m - 4:30 p.m. Eastern Time) or visit our dedicated Web sites for Healthcare Professionals at TylenolProfessional.com or ZyrtecProfessional.com.
Sincerely,
Edwin K. Kuffner, MD
Vice President, Medical Affairs
McNeil Consumer Healthcare
Friday, March 26, 2010
Alzheimer's Support Group Education Meeting
Our first support group met on Wednesday, March 24 with Mrs. Joyce Finkle as the speaker. Ms. Finkle is from the S.C. Chapter of Alzheimer's Association. She talked on topics of family caregiver support programs, sitters for families, supplies that were available and Alzheimer's voucher for cargivers. She recommened a book, The 36 Hour Day, to read which gives caregivers a lot of good ideas on how to handle situations.
With Alzheimer's, age is the greatest risk factor for the disease. Women have it more than men, because women live longer. A PET scan is the best imaging technique for diagnosis, along with blood work. She mentioned that Deb Lewis, with Catawba Triple A was a very good resource. She stressed the importance of exercise, eating right, taking Vitamin D, and staying brain healthy. Brain healthy things would include doing crossword puzzles, and catching a trivia game show on TV.
Mackey Family Practice would like to thank all those that attended this meeting. We are excited about hosting sessions, such as this, to keep our community up to date with the lastest information available for many disease processes. Be watching our Calender of Events on our home page to check out other educational sessions that will be coming up. If you are interested in attending any of our FREE sessions give us a call at 803-285-7414.
With Alzheimer's, age is the greatest risk factor for the disease. Women have it more than men, because women live longer. A PET scan is the best imaging technique for diagnosis, along with blood work. She mentioned that Deb Lewis, with Catawba Triple A was a very good resource. She stressed the importance of exercise, eating right, taking Vitamin D, and staying brain healthy. Brain healthy things would include doing crossword puzzles, and catching a trivia game show on TV.
Mackey Family Practice would like to thank all those that attended this meeting. We are excited about hosting sessions, such as this, to keep our community up to date with the lastest information available for many disease processes. Be watching our Calender of Events on our home page to check out other educational sessions that will be coming up. If you are interested in attending any of our FREE sessions give us a call at 803-285-7414.
Tuesday, March 23, 2010
RELAY FOR LIFE
Mackey Family Practice would like to invite everyone to come to the Relay for Life on April 23rd and 24th. It will start at 6pm at USC-Lancaster. We will be serving strawberry short cakes. The fee for these will be $3.00/each and all procedes will go to the Relay for Life. Come and join us for all the fun.
Thanks,
Crystal Campbell
Mackey Family Practice Team Captain
Thanks,
Crystal Campbell
Mackey Family Practice Team Captain
Subscribe to:
Posts (Atom)